MKI67 and neoplasm: Immunohistochemical staining of the tumour tissues showed decreased expression of Ki‐67, a well‐accepted proliferation marker, in the spautin‐1‐treated group compared with the control group, with further decreased expression in the combination group compared with the single‐drug group (Figure 7D).